ACC: Small but Significant Risk for Cardiomyopathy Seen With ADHD Meds
THURSDAY, March 28, 2024 (HealthDay News) -- Young adults prescribed stimulant medications for attention-deficit/hyperactivity disorder (ADHD) have an increased risk for cardiomyopathy, with the risk increasing with duration of treatment, according to a study scheduled for presentation at the annual meeting of the American College of Cardiology, held from April 6 to 8 in Atlanta.
Other Articles in this Edition
ACC: Small but Significant Risk for Cardiomyopathy Seen With ADHD Meds
ADHD medication proves most effective in treating symptoms, new study finds
ADHD Medications Linked to Reduction in Psychiatric Hospitalizations
Household chemicals endanger brain’s myelin-forming cells
6 Books for Adults Living With A.D.H.D.
Insight for Educators from Long-Time Educator and Parent Susan Lafond on Raising a Child with ADHD
Turning Challenges from ADHD into Strengths
Methylphenidate Does Not Affect Pubertal Maturation or Body Growth
Children with ADHD are more likely to be overweight
Motor Skills, Sensory Features Differ in Autism With, Without ADHD
Study says it’s time to highlight positive skills associated with neurodevelopmental conditions